SCHEMBL5284614

SCHEMBL5284614

O=C(O)CC(c1ccccc1)n1cnc2cc(NC(=O)Cc3c[nH]c4ccccc34)ccc21

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 2/20 0.46
ANO1 Q5XXA6 1/20 0.46
HRH3 Q9Y5N1 4/20 0.46
MAPT P10636 3/20 0.45
ALDH1A1 P00352 1/20 0.45
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
STAT3 P40763 1/20 0.44
RAB9A P51151 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CCKBR P32239 1/20 0.44
LMNA P02545 2/20 0.44
GLA P06280 1/20 0.43
PKM P14618 1/20 0.43
EDNRA P25101 1/20 0.43
HDAC1 Q13547 4/20 0.43
NTRK1 P04629 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2298363 0.93 ANO1 (0.46) ANO1HRH3MAPTALDH1A1MEN1
SCHEMBL2299363 0.92 MAPT (0.47) MAPTALDH1A1MEN1KMT2ARAB9A
SCHEMBL2292791 0.90 MAPT (0.54) MAPTALDH1A1MEN1KMT2ALMNA
SCHEMBL2293659 0.86 HTR2C (0.45) HRH3MEN1KMT2ARAB9ALMNA
SCHEMBL2294694 0.85 MAPT (0.47) MAPTALDH1A1MEN1KMT2ARAB9A
SCHEMBL12419753 0.84 HRH3 (0.50) ANO1HRH3MAPTALDH1A1MEN1
SCHEMBL2291392 0.83 KMT2A (0.51) NR1I2ALDH1A1MEN1KMT2ARAB9A
SCHEMBL2295280 0.83 KMT2A (0.50) NR1I2ANO1MEN1KMT2ARAB9A
SCHEMBL2296265 0.81 KMT2A (0.46) NR1I2MAPTALDH1A1MEN1KMT2A
SCHEMBL2295562 0.81 LMNA (0.48) NR1I2MAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828144-A2 INTEGRIN ANTAGONISTS USEFUL AS ANTICANCER AGENTS OSI Pharmaceuticals, Inc. (US) 2007-09-05 EP claimed
WO-2006053342-A2 INTEGRIN ANTAGONISTS USEFUL AS ANTICANCER AGENTS OSI PHARMACEUTICALS, INC. (US) 2006-05-18 WO claimed